| PMC full text: | Published online 2012 Oct 29. doi: 10.1007/s00586-012-2553-z
|
Table 4
Surgery versus conservative care in myelopathy patients
| Author | Outcome | Follow-up | Surgery | Conservative care | MD or RR | ||
|---|---|---|---|---|---|---|---|
| Mean (SD) | N | Mean (SD) | N | ||||
| Function | |||||||
| Short-term | |||||||
| Kadanka [18] | Modified JOA | 6 months | 13.4 (1.7) | 33 | 14.5 (2) | 35 | MD: 1.1 (0.19; 2.0) |
| Long-term | |||||||
| Heffez [19] (CCT) | SF-36 Physical functioning | 12 months | 36.1 (12.7) | 40 | 28.5 (9.6) | 31 | MD: 7.6 (2.1; 13.1) |
| Kadanka [18] | Modified JOA | 24 months | 13.7 (2) | 33 | 14.5 (1.8) | 35 | MD: 0.8 (−0.1; 1.7) |
| Kadanka [21] | Modified JOA | 10 years | 14.0 (2.3) | 22 | 15.0 (2.8) | 25 | MD: 1 (−0.5; 2.5) |
| Overall outcome | |||||||
| Short-term | |||||||
| Kadanka [18] | Self-perceived recovery | 6 months | 20 (61 %)a | 33 | 7 (20 %) | 35 | 41 %; RR = 3.03 (1.5; 6.2) |
| Long-term | |||||||
| Kadanka [18] | Self-perceived recovery | 24 months | 8 (24 %) | 33 | 4 (11 %) | 35 | 13 %; RR = 2.1 (0.7; 6.4) |
| Kadanka [21] | Self-perceived recovery | 10 years | 12 (36 %) | 33 | 11 (31 %) | 35 | 5 %; RR = 1.2 (0.6; 2.3) |
| Matsunaga [20] (CCT) | One-level improvement (Ranawat Classification) | ? | 9 (47 %) | 0 (0 %) | −9 % | ||
Continuous data are presented as a mean (SD), while dichotomous data are presented as a percentage, except where otherwise noted. All pain scales were standardized to a 100-point scale
MD mean difference, RR relative risk, ? no information
Bold values indicate the significant findings
aA significant mean subjective deterioration was found in the surgical group between 6 and 36 months